Dr. Steven Chen (IMAGE)

University of Miami Miller School of Medicine

Dr. Steven Chen

Caption

A study led by Dr. Steven Chen at Sylvester Comprehensive Cancer Center and published July 25 in Cell Reports identifies and validates a 10-gene biomarker that potentially predicts whether a stage II or III colon cancer patient will benefit from adjuvant chemotherapy. A secondary finding from the study suggests that the gene signature could potentially also predict whether immunotherapy would help some patients.

Credit

Photo by Sylvester

Usage Restrictions

None

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.